Newsletter

Int. Rev. Allergol. Clin. Immunol. Family Med., 2019, XXV/2: 057-064 Maximize

Int. Rev. Allergol. Clin. Immunol. Family Med., 2019, XXV/2: 057-064

Title: An insight into new approach to molecular markers of cervical cancer 

Authors: Liszcz A, Sobieraj MT, Sobiborowicz A, Maksimiuk M, Badowska-Kozakiewicz AM. 

More details

03-02-2019

0,00 zł

SUMMARY IN POLISH & ENGLISH. FULL ARTICLE ONLY IN ENGLISH.

An insight into new approach to molecular markers of cervical cancer


Liszcz A1, Sobieraj MT2, Sobiborowicz A3, Maksimiuk M3, Badowska-Kozakiewicz AM4.

1Grochowski Hospital, Warsaw; 2Public Central Teaching Clinical Hospital, Warsaw; 3Students’ Scientific Organization of Cancer Cell Biology, Department of Cancer Prevention, Medical University of Warsaw; 4Department of Cancer Prevention, Medical University of Warsaw

International Review of Medical Practice, 2019; Vol. 25, No. 2, 057

Cervical neoplasms belong to a very heterogenous group of neoplasms affecting many patients every year. Although its incidence is lowering, the mortality rate in Poland is much higher in comparison to other European countries. Histopathological examination is performed as a primary procedure to establish the appropriate diagnosis. A comprehensive understanding of cervical cancer biology is fundamental for more effective ways of diagnosis and developing new targets into treatment strategies. The aim of this paper was to analyse the impact of biological markers of hypoxia, angiogenesis, stromal invasion as well as influence of non-HPV viruses on histological malignancy and advancement of the disease and their possible clinical use in the course of cervical cancer screening and diagnostic process.

Key words: cervical cancer, cervical neoplasm, hypoxia, cyclooxygenase, angiogenesis, Ebstein-Barr virus, stromal invasion